2024-09-27 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**1. Performance Comparison with S&P 500 (VOO):**

CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management, and healthcare services. 

* **Cumulative Return (CVS):** -33.68%
* **Cumulative Return (VOO):** 133.29%
* **Performance Gap:**  -166.97% (This indicates CVS has underperformed the S&P 500 by a significant margin.)
* **Relative Divergence:** 0.26 (This implies the current performance gap between CVS and VOO sits at the 26th percentile of historical data.) 

**2. Recent Price Movement:**

* **Closing Price:** $58.64
* **5-Day Moving Average:** $57.99
* **20-Day Moving Average:** $57.67
* **60-Day Moving Average:** $58.20

The price is currently trading above all three moving averages, suggesting potential upward momentum.

**3. Technical Indicators:**

* **RSI:** 53.3 (Neutral, neither overbought nor oversold)
* **PPO:** 0.2 (Slightly bullish, indicating potential upward momentum)
* **Delta_Previous_Relative_Divergence:** -1.55 (Short-term downtrend, indicating a recent decline in relative performance compared to the previous period)
* **Expected_Return:** 0.0% (This is a projected maximum 5-year expected return based on current investment levels.)

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report (2024-08-07) shows a slight beat of the expected EPS. However, the earnings have been trending downwards in recent quarters. It will be crucial to observe the upcoming earnings announcements and assess the company's guidance for future earnings.

**5. News and Recent Issues:**

* **FINBOLD:** CVS is currently experiencing a decline in market value amidst a challenging healthcare landscape. 
* **Recent Market Outlook:** Analyst opinions are mixed, with some expecting a rebound due to the company's focus on healthcare services and potential for growth in the pharmacy benefit management sector. However, others remain cautious due to the competitive market and rising healthcare costs.
* **Performance Highlights:** CVS has been actively diversifying its portfolio and expanding its healthcare services offerings. 

**6. Overall Analysis:**

CVS is currently facing a challenging market environment with significant underperformance compared to the S&P 500. While the company is diversifying its portfolio and making strategic investments, the recent earnings trend has been concerning. Technical indicators suggest potential for upward momentum, but the overall picture remains cautious. Investors should carefully evaluate the company's future earnings reports and guidance to make informed investment decisions.

**7. Recommendation:**

While CVS has shown some signs of potential growth, the current market outlook and recent underperformance suggest a wait-and-see approach.  Further research and analysis are recommended before making any investment decisions. 
